<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02001142</url>
  </required_header>
  <id_info>
    <org_study_id>ADA 7-13-TS-35</org_study_id>
    <nct_id>NCT02001142</nct_id>
  </id_info>
  <brief_title>Effect of Exercise on Metabolic Health</brief_title>
  <official_title>Effect of Exercise on Novel Insulin Signaling Events in Human Muscle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Diabetes Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the main objectives of this study will be to assess potential differences in important
      risk factors associated with Metabolic Syndrome in overweight adults who do not participate
      in a regular exercise program compared with overweight individuals who do exercise regularly.
      In addition, we will determine the effects of a single, modest session of exercise on the
      body's ability to control blood sugar and regulate fat metabolism in obese sedentary adults
      vs. obese adults who live a physically active lifestyle. Our study focuses on identifying
      mechanisms responsible for improved insulin action related to regular exercise and to provide
      novel targets for preventing and treating type 2 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Sensitivity</measure>
    <time_frame>2-3 hours</time_frame>
    <description>A hyperinsulinemic-euglycemic clamp will be used to assess peripheral insulin sensitivity. Insulin sensitivity will be calculated from the clamp data as the rate of glucose infusion during the steady state period of the clamp - divided by the plasma insulin concentration at this time (units: mg/uU/ml/min)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resting Metabolic Rate</measure>
    <time_frame>20-30 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Meal Tolerance Test</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedentary Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>single session of exercise</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index [BMI] = 30-45 kg/m2, fasting blood glucose concentration must be &lt; or
             = to125 mg/dl, Hematocrit &gt; or = to 34%, all women must be pre-menopausal

        Exclusion Criteria:

          -  pregnancy or actively breastfeeding, weight instability (&gt; or = to Â± 5 lbs in the past
             month) evidence of cardiovascular or metabolic diseases, taking medications know to
             affect lipid and/or glucose metabolism.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey F Horowitz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suzette Howton, RD</last_name>
    <phone>734-647-9850</phone>
    <email>suzetter@med.umich.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Michigan Clincal Research Unit</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzette Howton, RD</last_name>
      <phone>734-647-9850</phone>
      <email>suzetter@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey F Horowitz, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2013</study_first_submitted>
  <study_first_submitted_qc>November 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2013</study_first_posted>
  <last_update_submitted>June 21, 2017</last_update_submitted>
  <last_update_submitted_qc>June 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Jeffrey F Horowitz</investigator_full_name>
    <investigator_title>Associate Professor, Movement Science, School of Kinesiology</investigator_title>
  </responsible_party>
  <keyword>Insulin Sensitivity</keyword>
  <keyword>Exercise</keyword>
  <keyword>Metabolism</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

